Skip to main navigation
Go to Upstream Bio homepage Upstream Bio, Targeting Inflammation at Its Source for Better Health
  • About
    • Leadership
    • Board
  • Science
    • TSLP
    • Publications
  • Pipeline
    • Verekitug
  • Patients
    • Clinical Trials
    • Disease Focus
  • Join Us
  • Investors
    • News Releases
    • Events & Presentations
      • Events
      • Presentations
    • Stock
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Committee Composition
    • Financial Information
      • SEC Filings
    • Shareholder Services
      • Investor FAQs
      • Email Alerts
      • Contact Us
About
Science
Pipeline
Patients
Join Us
Investor
News
Back
Team
  • Leadership
  • Board
  • Advisors
  • Investors
Back
News
  • Press Releases
  • In The News
Back
Investor
  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock
    • Stock Quote & Chart
  • Corporate Governance
    • Documents & Charters
    • Committee Composition
  • Financial Information
    • SEC Filings
  • Shareholder Services
    • Investor FAQs
    • Email Alerts
    • Contact Us

SEC Filing Details

Document Details

Form
10-Q
Filing Date
May 6, 2025
Document Date
Mar 31, 2025
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Upstream Bio
Issuer
UPSTREAM BIO, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT
Upstream Bio, Targeting Inflammation at Its Source for Better Health
  • LinkedIn
  • Twitter

info@upstreambio.com
890 Winter Street
Suite 200
Waltham, MA 02451

  • About
    • Board of Directors
    • Leadership
  • Science
    • TSLP
    • Publications
  • Pipeline
    • Verekitug
  • Patients
    • Clinical Trials
    • Disease Info
  • Join Us
  • Investors
© 2026 Upstream Bio | Privacy Policy | Terms of Use
EEA Investigators and Site Personnel Notice | Privacy Notice for Clinical Study Participants | Data Privacy Framework Privacy Notice